Literature DB >> 28941101

Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Michael J Owen1, Michael C O'Donovan1.   

Abstract

The idea that disturbances occurring early in brain development contribute to the pathogenesis of schizophrenia, often referred to as the neurodevelopmental hypothesis, has become widely accepted. Despite this, the disorder is viewed as being distinct nosologically, and by implication pathophysiologically and clinically, from syndromes such as autism spectrum disorders, attention-deficit/hyperactivity disorder (ADHD) and intellectual disability, which typically present in childhood and are grouped together as "neurodevelopmental disorders". An alternative view is that neurodevelopmental disorders, including schizophrenia, rather than being etiologically discrete entities, are better conceptualized as lying on an etiological and neurodevelopmental continuum, with the major clinical syndromes reflecting the severity, timing and predominant pattern of abnormal brain development and resulting functional abnormalities. It has also been suggested that, within the neurodevelopmental continuum, severe mental illnesses occupy a gradient of decreasing neurodevelopmental impairment as follows: intellectual disability, autism spectrum disorders, ADHD, schizophrenia and bipolar disorder. Recent genomic studies have identified large numbers of specific risk DNA changes and offer a direct and robust test of the predictions of the neurodevelopmental continuum model and gradient hypothesis. These findings are reviewed in detail. They not only support the view that schizophrenia is a disorder whose origins lie in disturbances of brain development, but also that it shares genetic risk and pathogenic mechanisms with the early onset neurodevelopmental disorders (intellectual disability, autism spectrum disorders and ADHD). They also support the idea that these disorders lie on a gradient of severity, implying that they differ to some extent quantitatively as well as qualitatively. These findings have important implications for nosology, clinical practice and research.
© 2017 World Psychiatric Association.

Entities:  

Keywords:  ADHD; Schizophrenia; autism; bipolar disorder; copy number variants; genomics; intellectual disability; neurodevelopment

Year:  2017        PMID: 28941101      PMCID: PMC5608820          DOI: 10.1002/wps.20440

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  75 in total

1.  Relationship between pregnancy experience and the development of certain neuropsychiatric disorders in childhood.

Authors:  A M LILIENFELD; B PASAMANICK; M ROGERS
Journal:  Am J Public Health Nations Health       Date:  1955-05

2.  Strong synaptic transmission impact by copy number variations in schizophrenia.

Authors:  Joseph T Glessner; Muredach P Reilly; Cecilia E Kim; Nagahide Takahashi; Anthony Albano; Cuiping Hou; Jonathan P Bradfield; Haitao Zhang; Patrick M A Sleiman; James H Flory; Marcin Imielinski; Edward C Frackelton; Rosetta Chiavacci; Kelly A Thomas; Maria Garris; Frederick G Otieno; Michael Davidson; Mark Weiser; Abraham Reichenberg; Kenneth L Davis; Joseph I Friedman; Thomas P Cappola; Kenneth B Margulies; Daniel J Rader; Struan F A Grant; Joseph D Buxbaum; Raquel E Gur; Hakon Hakonarson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-20       Impact factor: 11.205

3.  Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.

Authors:  George Kirov; Dilihan Gumus; Wei Chen; Nadine Norton; Lyudmila Georgieva; Murat Sari; Michael C O'Donovan; Fikret Erdogan; Michael J Owen; Hans-Hilger Ropers; Reinhard Ullmann
Journal:  Hum Mol Genet       Date:  2007-11-06       Impact factor: 6.150

4.  The Kraepelinian dichotomy - going, going... but still not gone.

Authors:  Nick Craddock; Michael J Owen
Journal:  Br J Psychiatry       Date:  2010-02       Impact factor: 9.319

Review 5.  Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders.

Authors:  Jonathan Sebat; Deborah L Levy; Shane E McCarthy
Journal:  Trends Genet       Date:  2009-10-31       Impact factor: 11.639

6.  Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Authors:  Tom Walsh; Jon M McClellan; Shane E McCarthy; Anjené M Addington; Sarah B Pierce; Greg M Cooper; Alex S Nord; Mary Kusenda; Dheeraj Malhotra; Abhishek Bhandari; Sunday M Stray; Caitlin F Rippey; Patricia Roccanova; Vlad Makarov; B Lakshmi; Robert L Findling; Linmarie Sikich; Thomas Stromberg; Barry Merriman; Nitin Gogtay; Philip Butler; Kristen Eckstrand; Laila Noory; Peter Gochman; Robert Long; Zugen Chen; Sean Davis; Carl Baker; Evan E Eichler; Paul S Meltzer; Stanley F Nelson; Andrew B Singleton; Ming K Lee; Judith L Rapoport; Mary-Claire King; Jonathan Sebat
Journal:  Science       Date:  2008-03-27       Impact factor: 47.728

7.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.

Authors:  Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman
Journal:  Lancet       Date:  2009-01-17       Impact factor: 79.321

8.  Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia.

Authors:  Detelina Grozeva; George Kirov; Dobril Ivanov; Ian R Jones; Lisa Jones; Elaine K Green; David M St Clair; Allan H Young; Nicol Ferrier; Anne E Farmer; Peter McGuffin; Peter A Holmans; Michael J Owen; Michael C O'Donovan; Nick Craddock
Journal:  Arch Gen Psychiatry       Date:  2010-04

Review 9.  Gene-environment interplay and psychopathology: multiple varieties but real effects.

Authors:  Michael Rutter; Terrie E Moffitt; Avshalom Caspi
Journal:  J Child Psychol Psychiatry       Date:  2006 Mar-Apr       Impact factor: 8.982

10.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

Authors:  Shaun M Purcell; Naomi R Wray; Jennifer L Stone; Peter M Visscher; Michael C O'Donovan; Patrick F Sullivan; Pamela Sklar
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

View more
  78 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  Psychopathology in 7-year-old children with familial high risk of developing schizophrenia spectrum psychosis or bipolar disorder - The Danish High Risk and Resilience Study - VIA 7, a population-based cohort study.

Authors:  Ditte Ellersgaard; Kerstin Jessica Plessen; Jens Richardt Jepsen; Katrine Soeborg Spang; Nicoline Hemager; Birgitte Klee Burton; Camilla Jerlang Christiani; Maja Gregersen; Anne Søndergaard; Md Jamal Uddin; Gry Poulsen; Aja Greve; Ditte Gantriis; Ole Mors; Merete Nordentoft; Anne Amalie Elgaard Thorup
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

3.  Harnessing Progress in Psychiatric Genetics to Advance Population Mental Health.

Authors:  Kathleen Ries Merikangas; Alison K Merikangas
Journal:  Am J Public Health       Date:  2019-06       Impact factor: 9.308

4.  Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

5.  High Rates of Genetic Diagnosis in Psychiatric Patients with and without Neurodevelopmental Disorders: Toward Improved Genetic Diagnosis in Psychiatric Populations.

Authors:  Joyce So; Venuja Sriretnakumar; Jessica Suddaby; Brianna Barsanti-Innes; Hanna Faghfoury; Timothy Gofine
Journal:  Can J Psychiatry       Date:  2020-06-04       Impact factor: 4.356

6.  Preterm birth subtypes, placental pathology findings, and risk of neurodevelopmental disabilities during childhood.

Authors:  Ramkripa Raghavan; Blandine Bustamante Helfrich; Sandra R Cerda; Yuelong Ji; Irina Burd; Guoying Wang; Xiumei Hong; Lingling Fu; Colleen Pearson; M Daniele Fallin; Barry Zuckerman; Xiaobin Wang
Journal:  Placenta       Date:  2019-06-14       Impact factor: 3.481

7.  CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

Authors:  O M Ogundele; C C Lee
Journal:  Brain Res Bull       Date:  2017-11-11       Impact factor: 4.077

8.  Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.

Authors:  Olav B Smeland; Shahram Bahrami; Oleksandr Frei; Alexey Shadrin; Kevin O'Connell; Jeanne Savage; Kyoko Watanabe; Florian Krull; Francesco Bettella; Nils Eiel Steen; Torill Ueland; Danielle Posthuma; Srdjan Djurovic; Anders M Dale; Ole A Andreassen
Journal:  Mol Psychiatry       Date:  2019-01-04       Impact factor: 15.992

9.  CRISPR-based functional evaluation of schizophrenia risk variants.

Authors:  Prashanth Rajarajan; Erin Flaherty; Schahram Akbarian; Kristen J Brennand
Journal:  Schizophr Res       Date:  2019-07-03       Impact factor: 4.939

10.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.